awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q35906490-CA85008F-756B-43C0-9CC4-F198DE025B3C
Q35906490-CA85008F-756B-43C0-9CC4-F198DE025B3C
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35906490-CA85008F-756B-43C0-9CC4-F198DE025B3C
SGLT-2 Inhibitors: A New Mechanism for Glycemic Control.
P2860
Q35906490-CA85008F-756B-43C0-9CC4-F198DE025B3C
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35906490-CA85008F-756B-43C0-9CC4-F198DE025B3C
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
1831fcf81f3c1e217fd2deabd1c3f0384f1bc54f
P2860
Canagliflozin compared with sitagliptin for patients with type 2 diabetes who do not have adequate glycemic control with metformin plus sulfonylurea: a 52-week randomized trial